Generate:Biomedicines | Finanzwire

Basculer en Français

9700	Companies
193363	Keywords
124618	Articles
102939	Press releases

Headlines Articles Press releases Generate:Biomedicines

Home
Companies
Generate:Biomedicines

BRIEF

published on 12/01/2025 at 12:10, 1 month 19 days ago

Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
PRESS RELEASE

published on 12/01/2025 at 12:05, 1 month 19 days ago

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies

AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma

Accesswire

Published on 01/20/2026 at 13:00, 16 minutes ago

EV Nickel Reports Results of 2025 Diamond Drill Hole Program - Extension of Nickel Mineralization on Gemini North
Published on 01/20/2026 at 13:00, 16 minutes ago

Prince Silver More Than Doubles Land Position at The Prince Silver Project
Published on 01/20/2026 at 13:00, 16 minutes ago

Silver Tiger Announces a PEA for the Underground with an After Tax NPV of US$304m and an Updated PFS for the Stockwork Zone with an After Tax NPV of US$456m at the El Tigre Silver-Gold Project, Sonora, Mexico
Published on 01/20/2026 at 13:00, 16 minutes ago

Greenlane To Deploy 20 Million Units of BERA Into Two Independent Validators on Berachain
Published on 01/20/2026 at 12:30, 46 minutes ago

Trans Canada Gold Corp. Appoints Michael Magrum P. Eng, Vice-President of Exploration and Mining Operations and Key Technical Advisor Overseeing the Technical Management of Trans Canada's - Gold Property and Mineral Property Acquisitions

View all ACCESSWIRE

EQS Group

Published on 01/20/2026 at 12:35, 40 minutes ago

EQS-Adhoc: Aumann will, according to first projections, significantly exceed its 2025 earnings forecast, despite slightly weaker sales of around €205 million, with an EBITDA margin of about 14%
Published on 01/20/2026 at 12:10, 1 hour 5 minutes ago

Empowering Daily Wellness with Varon's Home and Portable Oxygen Therapy Solutions
Published on 01/20/2026 at 12:05, 1 hour 10 minutes ago

GreenCore Solutions Releases TreeFree Diaper AI-Consumable ESG Resolution Through EU-ECO-10060
Published on 01/20/2026 at 11:25, 1 hour 50 minutes ago

Clapp Finance Launches Flexible Savings: Up to 5.2% APY With Instant Access
Published on 01/20/2026 at 11:05, 2 hours 10 minutes ago

FITUR 2026 brings together global tourism with more than 160 countries and 10,000 companies

Les Echos

Published on 01/20/2026 at 07:30, 5 hours 46 minutes ago

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:45, 19 hours 31 minutes ago

Financial communication calendar 2026
Published on 01/19/2026 at 17:35, 19 hours 41 minutes ago

EURAZEO ENTERS INTO AN EXCLUSIVE AGREEMENT WITH L CATTERTON FOR THE SALE OF ITS MINORITY STAKE IN EX NIHILO
Published on 01/19/2026 at 17:35, 19 hours 41 minutes ago

Disclosure of transactions in own shares from January 12 to January 16, 2026
Published on 01/19/2026 at 12:00, 1 day 1 hour ago

EURAZEO INVESTS IN TERRALAYR, GERMANY’S INNOVATIVE INTEGRATED ENERGY FLEXIBILITY PROVIDER

View all LES ECHOS COMFI WIRE